Exact Mass: 392.07184060000003
Exact Mass Matches: 392.07184060000003
Found 242 metabolites which its exact mass value is equals to given mass value 392.07184060000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Macarpine
A benzophenanthridine alkaloid that is sanguinarine bearing two methoxy substituents.
Epithienamycin E
C13H16N2O8S2 (392.03480559999997)
A member of the class of carbapenems that is (5R,6R)-3-{[(E)-2-aminoethenyl]sulfanyl}-6-[(1S)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid in which the free hydroxy and amino groups are carrying sulfo and acetyl substituents respectively. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Tiotropium
C19H22NO4S2+ (392.09901920000004)
Tiotropium is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.
2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
Garcimangosone D
Garcimangosone D is found in fruits. Garcimangosone D is a constituent of the dried fruit hulls of Garcinia mangostana (mangosteen). Constituent of the dried fruit hulls of Garcinia mangostana (mangosteen). Garcimangosone D is found in fruits.
1,3-Dipropyl-8-p-sulfophenylxanthine
C17H20N4O5S (392.11543500000005)
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists
2,6-Dioxo-9-phenyl-1,3-dipropylpurine-8-sulfonic acid
C17H20N4O5S (392.11543500000005)
Calcium ascorbate
Antioxidant. Calcium ascorbate is a compound with formula CaC12H14O12. It is the calcium salt of ascorbic acid. Antioxidant
Actos
C19H20N2O3S.HCl (392.0961346000001)
Pioglitazone hydrochloride is an aromatic ether. Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI05) A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. See also: Pioglitazone (has active moiety); Glimepiride; Pioglitazone Hydrochloride (component of); Alogliptin Benzoate; Pioglitazone Hydrochloride (component of). C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
Hosloppin
Ethyl 7-[2-(3-cyanoanilino)-2-oxoethoxy]-4-oxo-4H-chromene-2-carboxylate
Des(methylpiperazinyl) sildenafil acid
C17H20N4O5S (392.11543500000005)
ethyl 3-[(ethoxycarbonyl)methyl]-4,6-dihydro-8,9-dihydroxy-2,6-dioxo-2H-pyrano[3,4,5-de]chromene-4-carboxylate|pomegranatate
Rhodolauradiol acetate|Rhodolauradiol monoacetate
C17H26BrClO3 (392.07537360000003)
2,4-dihydroxyphenyl-(6-O-benzoyl)-O-beta-D-glucopyranoside|Neriifolin
2-C-??-D-Xylopyranosyl-1,3,6,7-tetrahydroxyxanthone
3,4-dihydroxyphenyl-(6-O-benzoyl)-O-beta-D-glucopyranoside
2-chloro-3,8-dihydroxy-1,4,6,9-tetramethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|hypophysciosporin
4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid monoether
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate [IIN-based: Match]
Ala Cys Cys Pro
Ala Cys Pro Cys
Ala Pro Cys Cys
Cys Ala Cys Pro
Cys Ala Pro Cys
Cys Cys Ala Pro
Cys Cys Pro Ala
Cys Pro Ala Cys
Cys Pro Cys Ala
Asp Asp Gly Ser
Asp Asp Ser Gly
Asp Gly Asp Ser
Asp Gly Ser Asp
Asp Ser Asp Gly
Asp Ser Gly Asp
b-D-Glucopyranuronic acid, 1-(6-methoxy-2-naphthaleneacetate)
Gly Asp Asp Ser
Gly Asp Ser Asp
Gly Ser Asp Asp
Pro Ala Cys Cys
Pro Cys Ala Cys
Pro Cys Cys Ala
Ser Asp Asp Gly
Ser Asp Gly Asp
Ser Gly Asp Asp
Desmethyldehydroamlodipine
C19H21ClN2O5 (392.11389260000004)
Acetamide,N-[[5-amino-2-[(4-aminophenyl)sulfonyl]phenyl]sulfonyl]-, sodium salt (1:1)
Metaclazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2,7-Diphenyl[1]benzothieno[3,2-b][1]benzothiophene
3,5-Difluoro-4-[difluoro(3,4,5-trifluorophenoxy)methyl]-4-propyl-1,1-biphenyl
C22H17F5O (392.11994919999995)
Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-galactopyranoside
Adenosine, 2-chloro-8-(methylamino)-, cyclic 3,5-(hydrogen phosphate)
C11H14ClN6O6P (392.04009440000004)
Anthra[2,1,9-def:6,5,10-def]diisochromene-1,3,8,10-tetraone
Parecoxib sodiuM
C19H17N2NaO4S (392.0806682000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
Ethyl 2,3,4,6-tetra-O-acetyl-alpha-D-thioglucopyranoside
4-(TRIFLUOROMETHYL)UMBELLIFERYL-BETA-D-GLUCOPYRANOSIDE
ethyl 2,3,4,6-tetra-o-acetyl-a-d-thiogalactopyranoside
METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide
C21H16N2O4S (392.08307360000003)
7-Amino-3-vinyl-3-cephem-4-carboxylic acid diphenylmethyl ester monohydrochloride
5-(4-METHOXYPHENYL)PYRROLO[2,1-D][1,5]BENZOTHIAZEPIN-4-OL N,N-DIMETHYLCARBAMATE
((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
BIS(ETHYLCYCLOPENTADIENYL)COBALT(III)
C14H20CoF6P (392.05387220000006)
((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
Ethyl 2,3,4,6-tetra-O-acetyl-b-D-thioglucopyranoside
4-(trifluoromethyl)umbelliferyl-beta-d-galactopyranoside
PX-478 2HCl
C13H20Cl4N2O3 (392.0227970000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one
C14H9F9N2O (392.05711319999995)
2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-
C18H20N2O4S2 (392.08644400000003)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM[1].
Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate
C21H16N2O4S (392.08307360000003)
N-(4,5-diphenyl-2-oxazolyl)-2-[(1-methyl-5-tetrazolyl)thio]acetamide
4-(5-methyl-2-furanyl)-2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
3-(1-Benzimidazolylmethyl)-6-[(4-methoxyphenoxy)methyl]-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
2-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methylthio]-6-phenyl-1H-pyrimidin-4-one
Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate
Tiotropium
C19H22NO4S2+ (392.09901920000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline
phosphono 4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoate
N-Pyridoxyl-2-methyl-L-glutamic acid-5-monophosphate
Pioglitazone Hydrochloride
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
2-Naphthyl 6-O-(carboxyacetyl)-beta-D-glucopyranoside
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-naphthalen-1-yloxyoxan-2-yl]methoxy]propanoic acid
calcium;2-(1,2-dihydroxyethyl)-3,4-dihydroxy-2H-furan-5-one
Rhizopycnolide A
A benzochromene that is benzo[c]chromen-6-one which is substituted by hydroxy groups at positions 1, 4 and 7, methoxy groups at positions 3 and 9, a methyl group at position 1, and a 2-carboxy-2-hydroxyethyl group at position 4, and in which the carboxy group has undergone condensation with the 4-hydroxy group to afford the corresponding spirocyclic lactone. It is active against the pathogenic bacteria Agrobacterium tumefaciens, Bacillus subtilis, Pseudomonas lachrymans, Ralstonia solanacearum, Staphylococcus hemolyticus, and Xanthomonas vesicatoria, with MIC values in the range 25-100 mug/mL.
2-[[4-(4-Fluorophenyl)-6-(trifluoromethyl)-2-pyrimidinyl]sulfonyl]acetic acid ethyl ester
Cyclopentanecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
N-[(E)-1-[4-[(4-chlorobenzoyl)amino]phenyl]ethylideneamino]pyridine-4-carboxamide
2-Thiophenecarboxylic acid [3-(3,5-dimethylphenoxy)-4-oxo-1-benzopyran-7-yl] ester
C22H16O5S (392.07184060000003)
4-[[[4-(2-Furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile
C20H16N4OS2 (392.07654859999997)
2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide
3-(4-amino-3,5-dichlorobenzoyl)-2-(3-amino-3-oxopropyl)-2H-indazole 1-oxide
2-(1,4-dioxo-3H-phthalazin-2-yl)-N-(5-methyl-4-phenyl-2-thiazolyl)acetamide
N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide
2-[[2-(5-Methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone
C21H16N2O2S2 (392.06531559999996)
(2E)-5-{3-[(difluoromethyl)sulfanyl]benzyl}-2-[(2E)-(pyridin-2-ylmethylidene)hydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
2-[4-(Difluoromethylthio)anilino]benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester
(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate
C21H16N2O4S (392.08307360000003)
(2E)-5-[[4-(difluoromethylsulfanyl)phenyl]methyl]-2-[(E)-pyridin-3-ylmethylidenehydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
(6R,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl] [(3R,4S,5S)-2,4,5-trihydroxyoxan-3-yl] hydrogen phosphate
C11H21O13P (392.07197460000003)
[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate
C19H20O7S (392.09296900000004)
6-[3-[(E)-but-1-enyl]-1-oxoisochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-[(E)-but-1-enyl]-1-oxoisochromen-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(E)-4-(1-oxoisochromen-3-yl)but-3-enoxy]oxane-2-carboxylic acid
[(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-hydroxyphenoxy)tetrahydropyran-2-yl]methyl 4-hydroxybenzoate
agrocinopine B
C11H21O13P (392.07197460000003)
A member of the class of agrocinopines that consists of beta-D-fructose and L-arabinose units joined via a phosphodiester linkage between position 4 of fructose and position 2 of arabinose.
2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
methyl 6-[6-(but-2-en-2-yl)-2,4-dihydroxy-3-methylphenoxy]-3-chloro-4-hydroxy-2-methylbenzoate
C20H21ClO6 (392.10265960000004)
(1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(5-methoxy-1-benzofuran-6-yl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid
(2r,3s)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
[(2r,3s,4s,5r,6s)-6-(3,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
(2r,3s,4r,5r,6s)-2-(2-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
2-c-β-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone
{"Ingredient_id": "HBIN005454","Ingredient_name": "2-c-\u03b2-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone","Alias": "NA","Ingredient_formula": "C18H16O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-{6,8-dihydroxy-7-methoxy-1-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzenecarboximidic acid
[(2r,3s,4s,5r,6s)-6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
[3,4,5-tris(acetyloxy)-6-ethoxythian-2-yl]methyl acetate
(1s,2s,3's,4r,4's,6's)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
2-(3-chloro-2-hydroxyphenyl)-3,5,7,8-tetramethoxychromen-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(4-hydroxyphenyl)methyl]chromen-4-one
2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methyl benzoate
1,3,6,7-tetrahydroxy-2-(3,4,5-trihydroxyoxan-2-yl)xanthen-9-one
7,9,11,12,14-pentahydroxy-13-methyl-12-(3-methyloxirane-2-carbonyl)-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-2-one
[6-(3,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
(1r,2r,3'r,4s,4'r,6'r)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
3-hydroxy-5-(2-hydroxy-2-{9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-2-yl}propyl)-3-(hydroxymethyl)oxolan-2-one
[3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
[6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
3-({2-[(1-hydroxyethylidene)amino]ethenyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
(5r,6r)-3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
(17r)-2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
(2s,3r,4s,5s,6r)-2-(2-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
1,3,6,7-tetrahydroxy-2-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]xanthen-9-one
(17s,18r)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
(1s,3s,4s,4'r)-1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
methyl 2-ethyl-5,7,10-trihydroxy-6,11-dioxotetracene-1-carboxylate
(2e)-1-(3-bromo-6-hydroxy-2,4-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
ethyl 4-(2-ethoxy-2-oxoethyl)-11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraene-6-carboxylate
2-[3,5-dihydroxy-2-(4-hydroxybenzoyl)phenoxy]-6-methyloxane-3,4,5-triol
(2r)-2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
2'-acetyl-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
(2s,4r,7r,8s,12r)-7,8,11-trihydroxy-12-(hydroxymethyl)-2-methyl-2-[(2r)-3-methyl-5-oxo-2h-furan-2-yl]-9-methylidene-5-oxatricyclo[6.3.1.0⁴,¹²]dodec-1(11)-ene-6,10-dione
5,7-dihydroxy-3,6,8-trimethoxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
[(2r,3s,4s,5s,6r)-3,4,5-tris(acetyloxy)-6-ethoxythian-2-yl]methyl acetate
(17r,18s)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
[(2r,3s,4r,5r,6s)-6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
(1s,3r,4s,4'r)-1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
(2s,7r)-10-acetyl-5,11,13-trihydroxy-7-methoxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,9,11-tetraen-4-yl acetate
(2s,3r,4s,5s,6r)-2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
10-acetyl-5,11,13-trihydroxy-7-methoxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,9,11-tetraen-4-yl acetate
6-[(3,4-dihydroxyphenyl)methyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
(1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[3-(5-methoxy-1-benzofuran-6-yl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid
[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
(5r,6r)-3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
(3r,5r)-3-hydroxy-5-[(2r)-2-hydroxy-2-[(2s)-9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-2-yl]propyl]-3-(hydroxymethyl)oxolan-2-one
ethyl (6r)-4-(2-ethoxy-2-oxoethyl)-11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraene-6-carboxylate
13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
(2s,3r,4r,5r,6s)-2-[3,5-dihydroxy-2-(4-hydroxybenzoyl)phenoxy]-6-methyloxane-3,4,5-triol
methyl 6-{6-[(2e)-but-2-en-2-yl]-2,4-dihydroxy-3-methylphenoxy}-3-chloro-4-hydroxy-2-methylbenzoate
C20H21ClO6 (392.10265960000004)